Impact of Changing Migraine Outcome on Pharmacist Interventions in a Health-System Specialty Pharmacy.

Health-system specialty pharmacies play a crucial role in managing complex medical conditions. They focus on specialized medication therapy management, especially for migraines. This study aimed to evaluate whether using different outcome measures affects pharmacist interventions. Researchers compared a non-disease specific patient-reported outcome measure to a disease-specific one. They conducted a pre-post, retrospective chart review at a single center. The study included 61 adult patients who received migraine medications. Results showed no significant difference in pharmacist interventions between the two groups. The migraine-specific outcome measure had a 15% intervention rate, while the non-specific measure had 14%. The findings suggest that both outcome measures are valuable for assessing migraine patients. However, using a disease-specific measure may help optimize migraine pharmacotherapy. This research indicates that the type of outcome measure does influence pharmacist intervention strategies for migraine management in health-system specialty pharmacies. Clinical relevance: This study shows that outcome measures can influence pharmacist strategies for migraine management.